Accessibility Tools

Events & Presentations

Presentation / Fact Sheet

Upcoming Events

6th ESCMID Conference on Vaccines: From Development to Real-World Clinical Practice and Global Health

September 10–13, 2025
Lisbon, Portugal
 

Presenter: Kelly T. McKee, Jr., MD, MPH; Chief Medical Officer, GeoVax Labs, Atlanta, Georgia
Format: Poster presentation (Poster: P060)
Session Details: Friday, September 12, 2025, Lisbon, Portugal
Topic: GEO-CM04S1, a multi-antigen COVID-19 vaccine for immunocompromised individuals: clinical evaluation to date.

For more information on the conference, please visit https://www.escmid.org/congress-events/6th-escmid-conference-on-vaccines.

International Workshop on Chronic Lymphocytic Leukemia (iwCLL 2025)

September 12-15, 2025
Krakow, Poland
 

Presenter: Alexey V. Danilov, MD, PhD; Professor, Department of Hematology and Transplantation; City of Hope National Medical Center, Duarte, California
Format: Poster presentation (Poster: 1717)
Session Details: Monday, September 15, 2025, from 08:15 to 09:40 CEST at the ICE Auditorium Hall (S1), Levels 0 & 1
Topic: MVA-based GEO-CMO4S1 vaccine results in improved cellular immune response in patients with chronic lymphocytic leukemia (CLL) compared with mRNA-based vaccine: initial results from a Phase II randomized study.

For more information on the conference, please visit https://www.iwcll.org/events/xxi-iwcll-12-15-september-2025-krakow-poland/

Past Events

H.C. Wainwright 27th Annual Global Investment Conference

September 8, 2025, 7:00 am ET
New York, NY
 
 

Emerging Growth Conference

August 20, 2025 - 3:40 PM ET 
 
Webcast
 

Q2 2025 GeoVax Labs, Inc. Corporate Update

July 28, 2025 - 4:30 PM ET

Webcast 

Emerging Growth Conference

July 16, 2025 - 1:10 PM ET
 

Webcast    

BIO International Convention

June 16-19, 2025

Boston, MA 

European Hematology Association (EHA) 2025 Hybrid Congress

June 12-15, 2025 - Milan, Italy and online

Poster Session 1 – Alexey V. Danilov, M.D., Ph.D., Associate Director of the Toni Stephenson Lymphoma Center and Professor in the Department of Hematology and Hematopoietic Cell Transplantation at the City of Hope Comprehensive Cancer Center in Duarte, California
Title: “MVA-Based GEO-CM04S1 Vaccine Results in Improved Cellular Immune Response in Patients with Chronic Lymphocytic Leukemia (CLL) Compared with mRNA-Based Vaccine: Initial Results of a Phase II Randomized Study”
When: June 14, 2025 - 18:30 - 18:30 CEST

 

Keystone Symposia on Vaccinology: Horizons Across Disease, Demography and Technology

June 4-7, 2025, Washington, DC

Poster Session 1 – Pratima Kumari, PhD, GeoVax Scientist
Poster Number: 1050
Title: “MVA‑vectored multi‑antigen COVID‑19 vaccines induce protective immunity against SARS‑CoV‑2 variants spanning Alpha to Omicron in preclinical animal models.”
When: June 5, 2025 at 12:00 p.m.

 

Poster Session 2 – Amany Elsharkawy, PhD, Georgia State University Scientist
Poster Number: 2047
Title: “GEO‑CM04S1 vaccine candidate maintains potent cross‑reactivity against original SARS‑CoV‑2 B.1 and Omicron subvariant XBB.1.5.”
When: June 6, 2025 at 7:30 p.m.

For more information on the Keystone Conference, please visit the Keystone Symposia website: https://www.keystonesymposia.org/conferences/conference-listing/meeting/onpage-program/g12025

Q1 2025 GeoVax Labs, Inc. Corporate Update

May 1, 2025 - 4:30 PM ET

Webcast   

American Association of Cancer Research

April 25-30, 2025, Chicago, IL

Speaker: J. Marc Pipas, MD, Executive Medical Director, Oncology
Session Title:            Viral-Vectored, Gene-Directed Prodrug Therapy (Gedeptin) in Needle-Accessible Solid Tumors
 
 

World Vaccine Congress Washington 2025

April 22-24, 2025 

Speaker:                                     Don J. Diamond, PhD, Director, Division of Vaccine Research & Professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center 
 
Session Title:                         Phase 2b Study Results That Evaluated and Compared GeoVax’s Multi-Antigen, Vaccine Candidate (GEO-CM04S1) to an Approved Vaccine Against COVID-19
 

 

Emerging Growth Conference

February 19, 2025 - 2:35 pm ET
Webcast
 

37th Annual Roth Conference

March 16-18, 2025

Dana Point, CA

Webcast  

Tribe Public’s Webinar Presentation and Q&A Event

March 6, 2025 - 8:30am PT / 11:30am ET

MPOX 2025: Navigating the Global Public Health Emergency

 

Emerging Growth Conference

February 19, 2025 - 2:35 pm ET
Webcast
 

BIO CEO & Investor Conference

February 10, 2025 
New York, NY
Presentation
 

Emerging Growth Conference

January 16, 2025 - 2:35 pm ET
Webcast
 

Biotech Showcase

January 14, 2025 - 10:30am PST
San Francisco, CA
Webcast
 

NobleCon20

December 3, 2024 
Boca Raton, FL 
 

Vaccines Summit

November 13-15, 2024

Boston, MA 

 

3rd Annual ROTH Healthcare Opportunities Conference

October 9, 2024, 12:30 pm ET
New York, NY
Presentation

 

Emerging Growth Conference

September 25, 2024 at 2:55 pm ET
 
 

H.C. Wainwright 26th Annual Global Investment Conference

September 9, 2024 - 7:00 am ET
New York, NY
H.C. Wainwright Webcast
 

Tribe Public’s Webinar Presentation and Q&A Event

August 23, 2024 - 11:00 am ET
Now Is Not the Time to Monkey(pox) Around
Webinar

 

Emerging Growth Conference

August 21, 2024 - 4:10 pm ET

Webcast   

Q2 2024 GeoVax Labs, Inc. Business Update

August 6,  2024 - 4:30 PM ET

Webcast  

SUBSCRIBE FOR UPDATES FROM GEOVAX
Register to receive email alerts for GeoVax press releases
GeoVax © 2025 All Rights Reserved.
WebCenntrix Web Design

Search